Paul Edick
Found 8 people in New York, Illinois, New Hampshire and other states
-
+91
-
+90
-
+89
-
-
+87
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-64.jpg "Arrested for drunk driving in Virginia (VA)")
Sponsored by SpokeoPaid Service
Paul J Edick
P*****@gmail.com — (313) 530-****
***** Northlawn Ave, East Lansing, MI
View full reportSponsored by SpokeoPaid Service
Paul Edick
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Gary Evans
Independent Consultant-Pharma, Leadership and ...
Michael S. Sheffield, MBA
NS Pharma, Inc.
Paul Ham, MBA
Flight Attendant - Delta Air Lines
Mark Costa
Eastman Chemical Company
Paul Edick
Sponsored by PeopleLookerPaid Service
Search for Paul Edick's city and state history
Search address history
Websites owned by Paul Edick
3gadvisors.com
Registered on September 3, 2013
Xeris Biopharma Announces CEO Succession Plan
Business Wire - Mon, 08 Jul 2024
Paul Edick '77 Appointed Chief Executive Officer of Durata Therapeutics
Hamilton College - Sun, 31 Oct 2010
Xeris CEO lists contemporary Lincoln Park eco-mansion for $6M
The Real Deal - Mon, 05 Dec 2022
Look inside a pharma exec's $6M Lincoln Park house with a vegetable garden on top
Crain's Chicago Business - Tue, 14 Feb 2023
Obituary | Robert V. "Doc" Edick
Sundquist Funeral Home - Fri, 05 Jun 2015
Spying new horizons, Xeris starts work on subcutaneous version of rare disease drug
Fierce Pharma - Mon, 28 Nov 2022
Xeris Biopharma’s glucagon injection becomes available in UK
PharmaTimes - Mon, 20 Dec 2021
Xeris Biopharma CEO Unveils Game-Changing Drug Innovations and Record Financial Success
Proactive Investors - Thu, 16 Nov 2023
Xeris Biopharma announces CEO succession
Crain's Chicago Business - Mon, 08 Jul 2024
Merck taps Xeris for ready-to-use versions of antibody products
Fierce Pharma - Tue, 26 Oct 2021
Paule Scantlebury - @pauledick
0 followers
![RecordAdvocate [microform] - Archives](https://archive.org/services/img/thewilliamsrecord_vol89 "RecordAdvocate [microform] - Archives")
Tales from the Trenches with Paul Edick, CEO of …
In April, Paul Edick, CEO of Xeris Pharmaceuticals, joined us at MATTER to share insights and learnings from his remarkable entrepreneurial …
Xeris Biopharma CEO Paul Edick to retire - MSN
Xeris Biopharma (NASDAQ: XERS) said Paul Edick will be retiring from his day-to-day operational and chairman role after more than seven years with the company. The firm has appointed …
Xeris CEO Paul Edick leaves | exechange
Paul Edick became CEO of the Company in 2021. Edick will serve in a senior advisory role to Xeris through February 1, 2026. The Company also announced that Marla S. …
Xeris Biopharma CEO Paul Edick to retire, John Shannon to …
Xeris Biopharma announced a CEO succession plan effective August 1, under which Paul Edick will be retiring from his day-to-day operational and chairman role at Xeris after more than …
Paul Edick Net Worth (2024) - wallmine
Paul Raymond Edick serves as Chairman of the Board, Chief Executive Officer of the Company. Prior to XERIS Pharmaceuticals, Mr. Edick was Founding Partner of 3G …
Xeris Biopharma Announces CEO Succession Plan - Yahoo …
John Shannon, President and Chief Operating Officer, to succeed Paul Edick as new CEO and Board Director. Transition timing aligns with the solid financial position of the …
The Future of Glucagon with Xeris Pharmaceuticals CEO Paul Edick
Paul Edick serves as the chairman and CEO for Xeris Pharmaceuticals, Inc., makers of the Gvoke Hypopen® and Gvoke® PFS (pre-filled syringe). Beyond Type 1 recently …
Paul Edick: Positions, Relations and Network - MarketScreener
at , Discover Paul Edick's known position history, network and 100 relationships. Find out about his known public assets.
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its …
Edick currently serves as Chairman and Chief Executive Officer of Xeris Pharmaceuticals, a publicly traded specialty pharmaceutical company leveraging its novel …
Paul Edick '77 Appointed Chief Executive Officer of Durata …
Paul Edick '77 has been appointed chief executive officer of Durata Therapeutics, a biopharmaceutical company addressing the growing need for new antibiotics to treat infectious …
96. Glucagon: busting the myths of this rescue drug to save lives …
Ever heard someone say you only need glucagon when you’re passed out? In my sit down with Xeris CEO Paul Edick, we discussed the misperceptions and myths surrounding …
Paul R Edick - Chairman & CEO @ Xeris Biopharma - Crunchbase
Paul R Edick is the Board Chairman at Xeris Biopharma. Mr. Edick joined Xeris Pharmaceuticals as Chairman and Chief Executive Officer in January 2017.
Xeris CEO Paul Edick Lists Lincoln Park Mansion For $6M - The …
The chairman and CEO of Xeris Pharmaceuticals is selling a contemporary mansion in Lincoln Park, seeking $6 million through a private, agents-only network listing. The …
Paul Edick Net Worth, Biography, and Insider Trading
The estimated net worth of Paul R. Edick is at least $5.17 million as of August 9th, 2023. Mr. Edick owns 2,288,064 shares of Xeris Biopharma stock worth more than $5,171,025 …
Xeris Biopharma Holdings, Inc. (XERS) CEO Paul Edick on Q3 …
We are joined this morning by Paul Edick, Chairman and CEO; and Steve Pieper, our CFO. Paul will provide opening remarks, Steve will provide details on our financial results …
Episode 281 - The Future of Closed Loop Diabetes Therapy
In this episode of Diabetics doing things, Rob interviews Paul Edick from Xeris Biopharma and Sean Saint from Beta Bionics. They discuss the formal partnership …